[Federal Register Volume 76, Number 115 (Wednesday, June 15, 2011)]
[Notices]
[Page 34968]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2011-14802]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Department of the Army


Intent to Grant an Exclusive License of U.S. Government-Owned 
Inventions

AGENCY: Department of the Army, DoD.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: In accordance with 35 U.S.C. 209(e), and 37 CFR 404.7(a)(1)(i) 
and 37 CFR 404.7(b)(1)(i), announcement is made of the intent to grant 
an exclusive, revocable license to the invention claimed in the PCT/
US2009/060091 (Publication Number WO 2010/042780), entitled ``Methods 
and Compositions for Treating Status Epilepticus and Seizures Causing 
Status Epilepticus'', to Biomedisyn Corporation with its principal 
place of business at 12 Indian Trail Road, Woodbridge, Connecticut 
06525.

ADDRESSES: Commander, U.S. Army Medical Research and Materiel Command, 
ATTN: Command Judge Advocate, MCMR-JA, 504 Scott Street, Fort Detrick, 
MD 21702-5012.

FOR FURTHER INFORMATION CONTACT: For licensing issues, Dr. Paul Mele, 
Office of Research & Technology Applications, (301) 619-6664. For 
patent issues, Ms. Elizabeth Arwine, Patent Attorney, (301) 619-7808; 
both at telefax (301) 619-5034.

SUPPLEMENTARY INFORMATION: Anyone wishing to object to grant of this 
license can file written objections along with supporting evidence, if 
any, within 15 days from the date of this publication. Written 
objections are to be filed with the Command Judge Advocate (see 
ADDRESSES).

Brenda S. Bowen,
Army Federal Register Liaison Officer.
[FR Doc. 2011-14802 Filed 6-14-11; 8:45 am]
BILLING CODE 3710-08-P